{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "11112649", "DateCompleted": {"Year": "2001", "Month": "02", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "26"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1523-7060", "JournalIssue": {"Volume": "2", "Issue": "25", "PubDate": {"Year": "2000", "Month": "Dec", "Day": "14"}}, "Title": "Organic letters", "ISOAbbreviation": "Org Lett"}, "ArticleTitle": "Enantiocontrolled synthesis of spirooxindoles based on the [5 + 2] cycloaddition of a Tp(CO)(2)Mo(pyridinyl) scaffold (Tp = hydridotrispyrazolylborate).", "Pagination": {"StartPage": "4083", "EndPage": "4086", "MedlinePgn": "4083-6"}, "Abstract": {"AbstractText": ["[structure] A [5 + 2] cycloaddition of the pyridinyl pi-complex (-)-1 (98% ee) to methyleneoxindole 2 afforded the spirooxindole complex (-)-3 in high enantiomeric purity. Complex (-)-3 was converted to pyrrolidine (-)-8 (97% ee), which is related to potent cytotoxic analogues of the spirotryprostatins alkaloids."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Sanford S. Atwood Chemistry Center, Emory University, 1515 Pierce Drive, Atlanta, Georgia, 30322, USA."}], "Identifier": [], "LastName": "Malinakova", "ForeName": "H C", "Initials": "HC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liebeskind", "ForeName": "L S", "Initials": "LS"}], "GrantList": [{"GrantID": "GM43107", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Org Lett", "NlmUniqueID": "100890393", "ISSNLinking": "1523-7052"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Borates"}, {"RegistryNumber": "0", "NameOfSubstance": "Indicators and Reagents"}, {"RegistryNumber": "0", "NameOfSubstance": "Indoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Organometallic Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrrolidines"}, {"RegistryNumber": "0", "NameOfSubstance": "hydridotrispyrazolylborate-(CO)2Mo(pyridinyl)"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Borates"}, {"QualifierName": [], "DescriptorName": "Cyclization"}, {"QualifierName": [], "DescriptorName": "Hydrolysis"}, {"QualifierName": [], "DescriptorName": "Indicators and Reagents"}, {"QualifierName": ["chemical synthesis"], "DescriptorName": "Indoles"}, {"QualifierName": ["chemistry"], "DescriptorName": "Organometallic Compounds"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": ["chemical synthesis"], "DescriptorName": "Pyrrolidines"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "12", "Day": "12", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "3", "Day": "3", "Hour": "10", "Minute": "1"}, {"Year": "2000", "Month": "12", "Day": "12", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11112649", "10.1021/ol000313z", "ol000313z"]}}], "PubmedBookArticle": []}